Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire CUHK Business School Research Finds Managerial Participation by Family Members in Chinese Family Businesses Linked to Fewer Problematic Transactions
Foreign ministry responds to report on Trump's barring US officials from attending April 30 celebrations 2.